Cargando…
Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell de...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887687/ https://www.ncbi.nlm.nih.gov/pubmed/29774530 http://dx.doi.org/10.1111/bph.14363 |
_version_ | 1783475070914527232 |
---|---|
author | Zhang, Junxia Liu, Dairu Zhang, Mao Zhang, Yan |
author_facet | Zhang, Junxia Liu, Dairu Zhang, Mao Zhang, Yan |
author_sort | Zhang, Junxia |
collection | PubMed |
description | Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell death, whereas necrosis has been regarded to be an unregulated process. Recent findings reveal that necrosis also occurs in a regulated manner and that it is closely related to the physiology and pathophysiology of many organs, including the heart. The recognition of necrosis as a regulated process mandates a re‐examination of cell death in the heart together with the mechanisms and therapy of cardiac diseases. In this study, we summarize the regulatory mechanisms of the programmed necrosis of cardiomyocytes, that is, the intrinsic (mitochondrial) and extrinsic (death receptor) pathways. Furthermore, the role of this programmed necrosis in various heart diseases is also delineated. Finally, we describe the currently known pharmacological inhibitors of several of the key regulatory molecules of regulated cell necrosis and the opportunities for their therapeutic use in cardiac disease. We intend to systemically summarize the recent progresses in the regulation and pathological significance of programmed cardiomyocyte necrosis along with its potential therapeutic applications to cardiac diseases. LINKED ARTICLES: This article is part of a themed section on Mitochondrial Pharmacology: Featured Mechanisms and Approaches for Therapy Translation. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc |
format | Online Article Text |
id | pubmed-6887687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68876872019-12-12 Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond Zhang, Junxia Liu, Dairu Zhang, Mao Zhang, Yan Br J Pharmacol Themed Section: Review Articles Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell death, whereas necrosis has been regarded to be an unregulated process. Recent findings reveal that necrosis also occurs in a regulated manner and that it is closely related to the physiology and pathophysiology of many organs, including the heart. The recognition of necrosis as a regulated process mandates a re‐examination of cell death in the heart together with the mechanisms and therapy of cardiac diseases. In this study, we summarize the regulatory mechanisms of the programmed necrosis of cardiomyocytes, that is, the intrinsic (mitochondrial) and extrinsic (death receptor) pathways. Furthermore, the role of this programmed necrosis in various heart diseases is also delineated. Finally, we describe the currently known pharmacological inhibitors of several of the key regulatory molecules of regulated cell necrosis and the opportunities for their therapeutic use in cardiac disease. We intend to systemically summarize the recent progresses in the regulation and pathological significance of programmed cardiomyocyte necrosis along with its potential therapeutic applications to cardiac diseases. LINKED ARTICLES: This article is part of a themed section on Mitochondrial Pharmacology: Featured Mechanisms and Approaches for Therapy Translation. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc John Wiley and Sons Inc. 2018-06-25 2019-11 /pmc/articles/PMC6887687/ /pubmed/29774530 http://dx.doi.org/10.1111/bph.14363 Text en © 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Themed Section: Review Articles Zhang, Junxia Liu, Dairu Zhang, Mao Zhang, Yan Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
title | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
title_full | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
title_fullStr | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
title_full_unstemmed | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
title_short | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
title_sort | programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
topic | Themed Section: Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887687/ https://www.ncbi.nlm.nih.gov/pubmed/29774530 http://dx.doi.org/10.1111/bph.14363 |
work_keys_str_mv | AT zhangjunxia programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond AT liudairu programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond AT zhangmao programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond AT zhangyan programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond |